Immusoft Announces Presentation of World’s First Patient Treated with an Engineered B Cell Therapy at Workshop Co-Hosted by FDA and ARM
Groundbreaking news from Immusoft reveals the treatment of the world’s first patient with a B cell-based therapy. With support from the FDA and ARM, the company showcases a next-generation approach focusing on scalability and re-dosability.
1 day ago
1 min read